Samara Capital
Healthcare
Samara Capital logs out of decade-long healthcare bet via secondary deal
Private equity firm Samara Capital has divested its entire shareholding in a decade-old healthcare portfolio company ......
Finance
Nuvama Wealth backer PAG nears one-fourth mark for new Asia buyout fund
Asia Pacific-focused private equity firm PAG has raised almost a quarter of the targeted amount for its fourth buyout ......
Consumer
Edelweiss fund makes 3.5x returns on its 4-year old bet in KFC operator
Homegrown private equity fund Edelweiss has clocked around 3.5 times returns on an around four-year old bet by selling partial...
Finance
Deals Digest: Companies raise $1.04 bn led by PE deals in healthcare & pharma
Companies raised $2.04 billion in venture capital (VC) and private equity (PE) funding this week, over 3 times higher than ......
Infrastructure
Delhivery's Spoton buy for $235 mn delivers 3.5x gains for Samara, Xponentia
Market-bound Delhivery Pvt. Ltd's acquisition of Spoton Logistics Pvt. Ltd has produced over three-and-a-half-fold returns...
Consumer
Asia PEs to invest in market-bound Sapphire, valuing Pizza Hut operator at $540 mn
Two Hong Kong-based secondaries private equity firms are likely to invest in Sapphire Foods India Pvt Ltd., one of the ......
Consumer
Pizza Hut operator Sapphire Foods to file for float soon, eyes $270 mn fundraise
Sapphire Foods India Pvt Ltd will file for float by next month to raise Rs 1,000-2,000 crore ($135-269 million), a ......
Healthcare
PE-backed stent maker decides to float, attracts banker pitches for IPO
A slew of bankers are angling for the underwriting business of an initial public offering (IPO) as India’s largest cardiac...
Consumer
Pizza Hut operator dials India, global private equity funds for pre-IPO dough
Sapphire Foods, an India franchisee for Yum! Brands’ KFC and Pizza Hut, is in early talks with global and local ......
Healthcare
Homegrown drugmaker, PE firm among suitors for Samara Capital's pharma platform
Samara Capital’s pharma platform has received interest from the country’s top drug maker and a homegrown private equity...








